Dvora Joseph Davey, MPH, PhD

Dr. Dvora Joseph Davey’s research focuses on how best to prevent and treat HIV and other sexually transmitted infections in peri-conception, pregnant women and couples. She has expertise in study design and use of epidemiological methods to inform interventions aimed at reducing the burden of HIV and related diseases on women, children, and families. Most recently, she is examining the combination of behavioral and biomedical approaches to HIV prevention among vulnerable populations. Dr. Joseph Davey is currently an Associate Professor (In Residence) in the Division of Infectious Diseases in the Geffen School of Medicine and in the Department of Epidemiology at the Fielding School of Public Health at UCLA. She is based in Cape Town, South Africa where she holds an Honorary Associate Professor Position at the University of Cape Town, South Africa School of Public Health’s Division of Epidemiology and Biostatistics. She is the PI of several NIH funded clinical trial and implementation science studies to evaluate how best to integrate PrEP and STI care into antenatal and postpartum care. She has been involved in research in Southern Africa since 2003 where she has developed and evaluated donor-funded epidemiological studies to inform effective, culturally relevant interventions aimed at reducing the burden of HIV and related diseases on women, children, and families. Prior to joining the faculty at UCLA, Dr. Joseph Davey was a Country Director and Technical Director for an NGO implementing HIV prevention and treatment programs in Mozambique. Dr. Joseph Davey completed her PhD in Epidemiology at UCLA and her MPH from Columbia University in Population and Family Health.

Contact: djosephdavey@mednet.ucla.edu

FEATURED PUBLICATIONS:

1. Chen-Charles, J., De Vos, L., Vundhla, P., Gebengu, A., Rousseau, E., Bekker, L. G., Peters, R., Mussa, A., Morroni, C., Toska, E., Babalola, C. M., Klausner, J. D., & Davey, D. J. (2025). Correction: Empowering Women’s PrEP Choices: Qualitative Insights into Long-Acting PrEP Preferences and Decision-Making during Pregnancy and Breastfeeding in South Africa and Botswana. AIDS and behavior, 10.1007/s10461-025-04925-2. Advance online publication.

2. Bekker, L. G., Joseph Davey, D., & Saidi, F. (2025). Two for two: lenacapavir during pregnancy and lactation. Lancet (London, England), 406(10512), 1560–1561.

3. Rotsaert, A., Essack, Z., Bosman, S., Davey, D. J., & Hensen, B. (2025). Oral pre-exposure prophylaxis initiation, continuation and adherence among pregnant and postpartum women receiving antenatal and postnatal care: a systematic review. Journal of the International AIDS Society, 28 Suppl 5(Suppl 5), e70035.

Last updated: 11/18/2025